In Segment A, members will acquire distinct doses and schedules of oral ABBV-744 pill to identify Risk-free dosing program. Extra members will be enrolled with the identified monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 are going to be offered as "incorporate-on" therapy. In Section https://michaelj555ufp7.shopping-wiki.com/user